Cancer Research Cell Death Mechanisms and Cancer Therapy Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, H.
Right arrow Articles by DuBois, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, H.
Right arrow Articles by DuBois, R. N.
[Cancer Research 61, 2670-2675, March 15, 2001]
© 2001 American Association for Cancer Research

Molecular Biology and Genetics

K-Ras-mediated Increase in Cyclooxygenase 2 mRNA Stability Involves Activation of the Protein Kinase B1

Hongmiao Sheng, Jinyi Shao and Raymond N. DuBois2

Departments of Medicine [H. S., J. S., R. N. D.] and Cell Biology [R. N. D.], Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Department of Veterans Affairs Medical Center, Nashville, Tennessee 37232

Cyclooxygenase (COX) 2 expression is regulated via the Ras signaling pathway, and induction of mutated Ras rapidly increases COX-2 levels in intestinal epithelial cells. Protein kinase B (Akt/PKB) is an important effector of Ras signaling and a critical component of Ras-mediated transformation. Here we investigate the role of Akt/PKB in K-Ras-mediated induction of COX-2. Rat intestinal epithelial cells (IEC-6) were transfected with an inducible K-RasVal12 cDNA (IEC-iK-Ras cells). Addition of 5 mM isopropyl-1-thio-ß-D-galactopyranoside induced the expression of K-RasVal12, followed by increased activity of extracellular signal-regulated kinase and Akt/PKB. COX-2 levels were dramatically increased after induction of K-RasVal12. Inhibition of MAPK/ERK kinase activity by PD 98059 completely blocked the K-Ras-mediated induction of COX-2, whereas inhibition of PI3K/Akt/PKB activity with LY 294002 or by expressing a dominant negative Akt (Akt-K179M) partially blocked the induction of COX-2 by K-Ras. Transient transfection of cells with phosphatidylinositol 3-kinase and Akt expression vectors revealed that PI3/Akt/PKB activity predominantly regulates the stability of COX-2 mRNA. Thus, Akt/PKB activity is involved in K-Ras-induced expression of COX-2 and stabilization of COX-2 mRNA largely depends on the activation of Akt/PKB.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
U. Dougherty, D. Cerasi, I. Taylor, M. Kocherginsky, U. Tekin, S. Badal, L. Aluri, A. Sehdev, S. Cerda, R. Mustafi, et al.
Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor-{alpha} and PTGS2
Clin. Cancer Res., November 15, 2009; 15(22): 6780 - 6789.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Shao, M.K. Washington, R. Saxena, and H. Sheng
Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin
Carcinogenesis, December 1, 2007; 28(12): 2476 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Mizukami, Y. Kohgo, and D. C. Chung
Hypoxia Inducible Factor-1 Independent Pathways in Tumor Angiogenesis
Clin. Cancer Res., October 1, 2007; 13(19): 5670 - 5674.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Klampfer, J. Huang, S. Shirasawa, T. Sasazuki, and L. Augenlicht
Histone Deacetylase Inhibitors Induce Cell Death Selectively in Cells That Harbor Activated kRasV12: The Role of Signal Transducers and Activators of Transcription 1 and p21
Cancer Res., September 15, 2007; 67(18): 8477 - 8485.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. C. Azim, H. Cao, X. Gao, M. Joo, A. B. Malik, R. B. van Breemen, R. T. Sadikot, G. Park, and J. W. Christman
Regulation of cyclooxygenase-2 expression by small GTPase Rac2 in bone marrow macrophages
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L668 - L673.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Koyama, Y. Matsuzaki, S. Yogosawa, T. Hitomi, M. Kawanaka, and T. Sakai
ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway
Mol. Cancer Ther., May 1, 2007; 6(5): 1579 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Stempelj, M. Kedinger, L. Augenlicht, and L. Klampfer
Essential Role of the JAK/STAT1 Signaling Pathway in the Expression of Inducible Nitric-oxide Synthase in Intestinal Epithelial Cells and Its Regulation by Butyrate
J. Biol. Chem., March 30, 2007; 282(13): 9797 - 9804.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Gervais, C. Dugourd, L. Muller, C. Ardidie, B. Canton, L. Loviconi, P. Corvol, H. Chneiweiss, and C. Monnot
Akt Down-Regulates ERK1/2 Nuclear Localization and Angiotensin II-induced Cell Proliferation through PEA-15
Mol. Biol. Cell, September 1, 2006; 17(9): 3940 - 3951.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Upadhyay, C. Liu, A. Chatterjee, M. O. Hoque, M. S. Kim, J. Engles, W. Westra, B. Trink, E. Ratovitski, and D. Sidransky
LKB1/STK11 Suppresses Cyclooxygenase-2 Induction and Cellular Invasion through PEA3 in Lung Cancer
Cancer Res., August 15, 2006; 66(16): 7870 - 7879.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
W.-C. Tsai, S.-T. Tsai, Y.-T. Jin, and L.-W. Wu
Cyclooxygenase-2 Is Involved in S100A2-Mediated Tumor Suppression in Squamous Cell Carcinoma
Mol. Cancer Res., August 1, 2006; 4(8): 539 - 547.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Hoang, L. Zhu, Y. Shi, P. Frost, H. Yan, S. Sharma, S. Sharma, L. Goodglick, S. Dubinett, and A. Lichtenstein
Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance
Blood, June 1, 2006; 107(11): 4484 - 4490.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Thiel, M. Heinonen, J. Rintahaka, T. Hallikainen, A. Hemmes, D. A. Dixon, C. Haglund, and A. Ristimaki
Expression of Cyclooxygenase-2 Is Regulated by Glycogen Synthase Kinase-3beta in Gastric Cancer Cells
J. Biol. Chem., February 24, 2006; 281(8): 4564 - 4569.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. G. Banerjee, I. Bhattacharyya, and J. K. Vishwanatha
Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia
Mol. Cancer Ther., June 1, 2005; 4(6): 865 - 875.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Daikoku, D. Wang, S. Tranguch, J. D. Morrow, S. Orsulic, R. N. DuBois, and S. K. Dey
Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer
Cancer Res., May 1, 2005; 65(9): 3735 - 3744.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Symowicz, B. P. Adley, M. M.M. Woo, N. Auersperg, L. G. Hudson, and M. S. Stack
Cyclooxygenase-2 Functions as a Downstream Mediator of Lysophosphatidic Acid to Promote Aggressive Behavior in Ovarian Carcinoma Cells
Cancer Res., March 15, 2005; 65(6): 2234 - 2242.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Sheu, F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S.-H. Liu
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase-Regulated Cyclooxygenase-2 Pathway
Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 539 - 545.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. W. Slice, T. Chiu, and E. Rozengurt
Angiotensin II and Epidermal Growth Factor Induce Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Small GTPases Using Distinct Signaling Pathways
J. Biol. Chem., January 14, 2005; 280(2): 1582 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.-H. Chou, L.-H. Wei, M.-L. Kuo, Y.-J. Huang, K.-P. Lai, C.-A. Chen, and C.-Y. Hsieh
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor
Carcinogenesis, January 1, 2005; 26(1): 45 - 52.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Maciag, G. Sithanandam, and L. M. Anderson
Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells
Carcinogenesis, November 1, 2004; 25(11): 2231 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B.-C. Chen, C.-C. Yu, H.-C. Lei, M.-S. Chang, M.-J. Hsu, C.-L. Huang, M.-C. Chen, J.-R. Sheu, T.-F. Chen, T.-L. Chen, et al.
Bradykinin B2 Receptor Mediates NF-{kappa}B Activation and Cyclooxygenase-2 Expression via the Ras/Raf-1/ERK Pathway in Human Airway Epithelial Cells
J. Immunol., October 15, 2004; 173(8): 5219 - 5228.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M.-S. Chang, W.-S. Lee, B.-C. Chen, J.-R. Sheu, and C.-H. Lin
YC-1-Induced Cyclooxygenase-2 Expression Is Mediated by cGMP-Dependent Activations of Ras, Phosphoinositide-3-OH-kinase, Akt, and Nuclear Factor-{kappa}B in Human Pulmonary Epithelial Cells
Mol. Pharmacol., September 1, 2004; 66(3): 561 - 571.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-C. Chen, Y.-S. Chang, J.-C. Kang, M.-J. Hsu, J.-R. Sheu, T.-L. Chen, C.-M. Teng, and C.-H. Lin
Peptidoglycan Induces Nuclear Factor-{kappa}B Activation and Cyclooxygenase-2 Expression via Ras, Raf-1, and ERK in RAW 264.7 Macrophages
J. Biol. Chem., May 14, 2004; 279(20): 20889 - 20897.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. D. WARNER and J. A. MITCHELL
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
FASEB J, May 1, 2004; 18(7): 790 - 804.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Shao, B. M. Evers, and H. Sheng
Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer Cells
J. Biol. Chem., April 2, 2004; 279(14): 14287 - 14293.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J. Du, B. Jiang, R. J. Coffey, and J. Barnard
Raf and RhoA Cooperate to Transform Intestinal Epithelial Cells and Induce Growth Resistance to Transforming Growth Factor {beta}
Mol. Cancer Res., April 1, 2004; 2(4): 233 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H.-Y. Lee, Y.-A. Suh, J. W. Kosmeder, J. M. Pezzuto, W. K. Hong, and J. M. Kurie
Deguelin-Induced Inhibition of Cyclooxygenase-2 Expression in Human Bronchial Epithelial Cells
Clin. Cancer Res., February 1, 2004; 10(3): 1074 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Shao, B. M. Evers, and H. Sheng
Roles of Phosphatidylinositol 3'-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras-Mediated Transformation of Intestinal Epithelial Cells
Cancer Res., January 1, 2004; 64(1): 229 - 235.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Puxeddu, N. Mitsutake, J. A. Knauf, S. Moretti, H. W. Kim, K. A. Seta, D. Brockman, L. Myatt, D. E. Millhorn, and J. A. Fagin
Microsomal Prostaglandin E2 Synthase-1 Is Induced by Conditional Expression of RET/PTC in Thyroid PCCL3 Cells through the Activation of the MEK-ERK Pathway
J. Biol. Chem., December 26, 2003; 278(52): 52131 - 52138.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Sheng, J Shao, C M Townsend jr, and B M Evers
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells
Gut, October 1, 2003; 52(10): 1472 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Khare, S. Cerda, R. K. Wali, F. C. von Lintig, M. Tretiakova, L. Joseph, D. Stoiber, G. Cohen, K. Nimmagadda, J. Hart, et al.
Ursodeoxycholic Acid Inhibits Ras Mutations, Wild-type Ras Activation, and Cyclooxygenase-2 Expression in Colon Cancer
Cancer Res., July 1, 2003; 63(13): 3517 - 3523.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
S. A. Benitah, P. F. Valeron, and J. C. Lacal
ROCK and Nuclear Factor-{kappa}B-dependent Activation of Cyclooxygenase-2 by Rho GTPases: Effects on Tumor Growth and Therapeutic Consequences
Mol. Biol. Cell, July 1, 2003; 14(7): 3041 - 3054.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Sengupta, B.-C. Jang, M.-T. Wu, J.-H. Paik, H. Furneaux, and T. Hla
The RNA-binding Protein HuR Regulates the Expression of Cyclooxygenase-2
J. Biol. Chem., June 27, 2003; 278(27): 25227 - 25233.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
G. Tiwari, H. Sakaue, J. R. Pollack, and R. A. Roth
Gene Expression Profiling in Prostate Cancer Cells With Akt Activation Reveals Fra-1 As an Akt-Inducible Gene
Mol. Cancer Res., April 1, 2003; 1(6): 475 - 484.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Liang, W. Jin, C. Knuefermann, M. Schmidt, G. B. Mills, K. K. Ang, L. Milas, and Z. Fan
Targeting the Phosphatidylinositol 3-Kinase/Akt Pathway for Enhancing Breast Cancer Cells to Radiotherapy
Mol. Cancer Ther., April 1, 2003; 2(4): 353 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Heuze-Vourc'h, L. Zhu, K. Krysan, R. K. Batra, S. Sharma, and S. M. Dubinett
Abnormal Interleukin 10R{alpha} Expression Contributes to the Maintenance of Elevated Cyclooxygenase-2 in Non-Small Cell Lung Cancer Cells
Cancer Res., February 15, 2003; 63(4): 766 - 770.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. L. Rice, M. Washington, S. Schleman, K. S. Beard, L. J. Driggers, and D. J. Ahnen
Sulindac Sulfide Inhibits Epidermal Growth Factor-induced Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells
Cancer Res., February 1, 2003; 63(3): 616 - 620.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Araki, S. Okamura, S. P. Hussain, M. Nagashima, P. He, M. Shiseki, K. Miura, and C. C. Harris
Regulation of Cyclooxygenase-2 Expression by the Wnt and Ras Pathways
Cancer Res., February 1, 2003; 63(3): 728 - 734.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Dong, K. Guda, P. R. Nambiar, A. Rezaie, G. S. Belinsky, G. Lambeau, C. Giardina, and D. W. Rosenberg
Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis
Carcinogenesis, February 1, 2003; 24(2): 307 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Y. Moon and J. J. Pestka
Vomitoxin-Induced Cyclooxygenase-2 Gene Expression in Macrophages Mediated by Activation of ERK and p38 but Not JNK Mitogen-Activated Protein Kinases
Toxicol. Sci., October 1, 2002; 69(2): 373 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Monick, P. K. Robeff, N. S. Butler, D. M. Flaherty, A. B. Carter, M. W. Peterson, and G. W. Hunninghake
Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA
J. Biol. Chem., August 30, 2002; 277(36): 32992 - 33000.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Ferrandina, L. Lauriola, G. F. Zannoni, A. Fagotti, F. Fanfani, F. Legge, N. Maggiano, M. Gessi, S. Mancuso, F. O. Ranelletti, et al.
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
Ann. Onc., August 1, 2002; 13(8): 1205 - 1211.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Shao, H. Sheng, and R. N. DuBois
Peroxisome Proliferator-activated Receptors Modulate K-Ras-mediated Transformation of Intestinal Epithelial Cells
Cancer Res., June 1, 2002; 62(11): 3282 - 3288.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Ferrandina, L. Lauriola, M. G. Distefano, G. F. Zannoni, M. Gessi, F. Legge, N. Maggiano, S. Mancuso, A. Capelli, G. Scambia, et al.
Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients
J. Clin. Oncol., February 15, 2002; 20(4): 973 - 981.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.